Cellectar Biosciences, Inc.
USD2.79
+0.19 (+7.31%)
CEO
James V. Caruso
IPO Date
2005-11-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.59
Prev. Close
$2.60
Day Low
$2.59
Day High
$2.92
52W Low
$2.20
52W High
$6.52
Market Cap
$0.01B
Volume
0.17M
| -0.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 310.5% | -354.2% | -0.04 | 0.41 | -0.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -333.4% | -147.3% | 0.06 | 1.78 | -0.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -73.0% | -64.8% | 0.01 | 9.16 | -1.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -27.5% | -25.7% | 0.01 | 16.26 | -2.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -155.6% | -115.0% | 0.06 | 4.11 | -1.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -99.8% | -87.9% | 0.00 | 8.60 | -0.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -126.1% | -105.4% | 0.00 | 4.95 | -1.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -45.6% | -40.3% | 0.01 | 7.47 | -0.9 |
| -0.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -47.4% | -30.4% | 0.05 | 2.77 | -1.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -73.0% | -39.8% | 0.06 | 2.15 | -0.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -80.0% | -41.2% | 0.06 | 2.47 | -0.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -16.5% | -9.2% | 0.03 | 2.58 | -1.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -96.7% | -39.3% | 0.03 | 1.77 | -1.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -6.7% | -3.1% | 0.04 | 1.84 | -3.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -191.9% | -62.1% | 0.04 | 1.45 | -1.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 57.2% | -65.3% | -0.04 | 0.41 | -1.7 |